Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,040.28
918.35
933.39
956.35
861.03
1,008.20
763.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,040.28
918.35
933.39
956.35
861.03
1,008.20
763.69
Raw Material Cost
389.20
392.35
409.88
392.30
256.45
467.90
242.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.63
0.73
1.42
1.59
1.49
0.15
1.75
Selling and Distribution Expenses
374.59
344.00
391.10
372.52
378.86
307.80
387.13
Other Expenses
4.77
6.51
10.02
6.72
5.10
6.80
7.66
Total Expenditure (Excl Depreciation)
812.12
802.15
902.59
833.58
687.83
843.83
707.64
Operating Profit (PBDIT) excl Other Income
228.2
116.19999999999999
30.8
122.8
173.2
164.4
56
Other Income
3.21
5.50
89.82
4.19
53.74
6.26
-131.71
Operating Profit (PBDIT)
244.68
173.62
145.59
169.03
249.87
223.09
-45.63
Interest
0.63
0.73
1.42
1.59
1.49
0.15
1.75
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
651.08
526.00
523.51
564.05
604.58
540.29
521.54
Depreciation
59.08
59.08
50.80
50.80
59.28
59.28
61.18
Profit Before Tax
184.97
113.81
93.37
116.65
189.10
163.66
-108.55
Tax
27.23
17.93
21.76
14.25
27.52
19.72
13.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
150.67
93.89
42.96
98.42
164.28
143.98
-133.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
150.67
93.89
42.96
98.42
164.28
143.98
-133.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.55
-3.52
13.78
1.36
-6.35
-5.82
-9.77
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
154.22
90.37
56.73
99.77
157.93
138.16
-142.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,962.85
6,078.91
6,035.11
5,992.25
6,004.12
6,033.71
5,843.50
Earnings per share (EPS)
0.16
0.09
0.04
0.1
0.17
0.15
-0.13
Diluted Earnings per share
0.16
0.09
0.04
0.1
0.17
0.15
-0.13
Operating Profit Margin (Excl OI)
17.53%
11.87%
0.53%
11.92%
15.89%
15.63%
3.26%
Gross Profit Margin
23.46%
18.83%
15.45%
17.51%
28.85%
22.11%
-6.2%
PAT Margin
14.48%
10.22%
4.6%
10.29%
19.08%
14.28%
-17.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 20.82% vs -21.72% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -2.34% vs -17.42% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 23.15% vs -22.73% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -60.00% vs 400.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Zhejiang Xianju Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,040.28
0
1,040.28
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,040.28
0
1,040.28
Raw Material Cost
389.20
0
389.20
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.63
0
0.63
Selling and Distribution Expenses
374.59
0
374.59
Other Expenses
4.77
0.00
4.77
Total Expenditure (Excl Depreciation)
812.12
0
812.12
Operating Profit (PBDIT) excl Other Income
228.16
0.00
228.16
Other Income
3.21
0
3.21
Operating Profit (PBDIT)
244.68
0
244.68
Interest
0.63
0
0.63
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
651.08
0
651.08
Depreciation
59.08
0
59.08
Profit Before Tax
184.97
0
184.97
Tax
27.23
0
27.23
Provisions and contingencies
0
0
0.00
Profit After Tax
150.67
0
150.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
150.67
0
150.67
Share in Profit of Associates
0
0
0.00
Minority Interest
3.55
0
3.55
Other related items
0.00
0.00
0.00
Consolidated Net Profit
154.22
0
154.22
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,962.85
0
5,962.85
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
17.53%
0%
0.00
17.53%
Gross Profit Margin
23.46%
0%
0.00
23.46%
PAT Margin
14.48%
0%
0.00
14.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 104.03 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 13.29% vs -1.62% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.82% vs -21.72% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.42 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 70.58% vs 59.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -2.34% vs -17.42% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.15 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 43.66% vs 201.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 23.15% vs -22.73% in Jun 2025
Quarterly - Interest
Interest 0.06 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -14.29% vs -50.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -60.00% vs 400.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.53%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
